We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Spinal Restoration Reaches Agreement on Special Protocol for Phase III Trial
Spinal Restoration Reaches Agreement on Special Protocol for Phase III Trial
December 15, 2009
Spinal Restoration, Inc. announced Tuesday it has received
a Special Protocol Assessment concurrence letter from the U.S. Food and Drug Administration (FDA) for the design of its Phase 3 study of the Biostat System
for the treatment of chronic discogenic low back pain. Earth Times
